{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:56:19Z","timestamp":1790898979159,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.adro.2026.102166","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:43:22Z","timestamp":1786603402000},"page":"102166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Outcomes of Single- and Split-Fraction Low-Dose Radiation in Mycosis Fungoides"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3357-0728","authenticated-orcid":false,"given":"Sarah J.","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Trepanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushya","family":"Ajmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Lansigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joi B.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102166_bib0001","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11899-017-0387-9","article-title":"Multidisciplinary management of mycosis fungoides\/S\u00e9zary syndrome","volume":"12","author":"Berg","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.adro.2026.102166_bib0002","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaad.2021.04.080","article-title":"Primary cutaneous T-cell lymphomas other than mycosis fungoides and S\u00e9zary syndrome. Part I: Clinical and histologic features and diagnosis","volume":"85","author":"Stoll","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adro.2026.102166_bib0003","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/cancers16050937","article-title":"Evaluation of quality of life and treatment satisfaction in newly diagnosed cutaneous T-cell lymphoma patients","volume":"16","author":"Ottevanger","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.adro.2026.102166_bib0004","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bjd.19252","article-title":"Treatment of early-stage mycosis fungoides: Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study","volume":"184","author":"Quaglino","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adro.2026.102166_bib0005","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102166_bib0006","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-18-4147","article-title":"Radiotherapy eradicates malignant T cells and is associated with improved survival in early-stage mycosis fungoides","volume":"26","author":"O'Malley","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2026.102166_bib0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"International Lymphoma Radiation Oncology Group. Modern radiation therapy for primary cutaneous lymphomas: Field and dose guidelines from the international lymphoma radiation oncology group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102166_bib0008","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0360-3016(90)90306-5","article-title":"The radiation therapy of early stage cutaneous T-cell lymphoma","volume":"18","author":"Micaily","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102166_bib0009","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21873\/anticanres.13105","article-title":"Cutaneous T-cell lymphoma: Trends in radiation doses and patterns of care 2004-2015","volume":"39","author":"Miccio","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2026.102166_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115064","article-title":"Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group","volume":"212","author":"Elsayad","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2026.102166_bib0011","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.3390\/curroncol31090400","article-title":"Mogamulizumab and concomitant hypofractionated low-dose total skin electron beam therapy (2 \u00d7 4 Gy) in cutaneous T-cell lymphoma: Proof of principle, report of two cases","volume":"31","author":"Oymanns","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.adro.2026.102166_bib0012","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jrh.12413","article-title":"Evaluating travel distance to radiation facilities among rural and urban breast cancer patients in the medicare population","volume":"36","author":"Longacre","year":"2020","journal-title":"J Rural Health"},{"key":"10.1016\/j.adro.2026.102166_bib0013","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jrh.12693","article-title":"The interaction of rurality and rare cancers for travel time to cancer care","volume":"39","author":"Onega","year":"2023","journal-title":"J Rural Health"},{"key":"10.1016\/j.adro.2026.102166_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.61021","article-title":"Cross-state travel for cancer care and implications for telehealth reciprocity","volume":"8","author":"Moen","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.adro.2026.102166_bib0015","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.surg.2023.07.004","article-title":"Impact of travel burden on the treatment of stage I and II breast cancer: A National Cancer Database analysis","volume":"174","author":"Perry","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.adro.2026.102166_bib0016","article-title":"The relationship between travel distance for treatment and outcomes in patients undergoing radiation therapy: A systematic review","volume":"9","author":"Silverwood","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102166_bib0017","article-title":"Expenditures and use of hypofractionated radiation therapy treating breast cancer among medicare advantage enrollees, 2009 to 2017","volume":"9","author":"Saulsberry","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102166_bib0018","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaad.2017.07.053","article-title":"Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study","volume":"78","author":"Goyal","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adro.2026.102166_bib0019","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ijrobp.2025.07.054","article-title":"Radiation therapy utilization for primary cutaneous T-cell lymphoma is lowest among patients living in the most geographically accessible areas: An Australian study","volume":"123","author":"Campbell","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102166_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.semradonc.2024.08.005","article-title":"Breaking down the barriers for patients with cutaneous T-cell lymphoma: Current controversies and challenges for radiation oncologists in 2024","volume":"35","author":"Campbell","year":"2025","journal-title":"Semin Radiat Oncol"},{"issue":"suppl 2","key":"10.1016\/j.adro.2026.102166_bib0021","first-page":"S6","article-title":"Quantifying non-clinical outcomes of ultra-hypofractionated breast radiotherapy in Western NSW-A narrative review","volume":"72","author":"Yeo","year":"2025","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.adro.2026.102166_bib0022","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.breast.2010.03.003","article-title":"Hypofractionated breast radiotherapy: Financial and economic consequences","volume":"19","author":"Lievens","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.adro.2026.102166_bib0023","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2022.06.014","article-title":"Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFIT","volume":"173","author":"Zhou","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102166_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.841356","article-title":"Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer","volume":"12","author":"He","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2026.102166_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.45","article-title":"Health-related quality of life in cutaneous T-cell lymphoma: A cross-sectional survey study","volume":"1","author":"Shinohara","year":"2021","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.adro.2026.102166_bib0026","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/jdv.20357","article-title":"Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and S\u00e9zary syndrome","volume":"39","author":"Ortiz Romero","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:44:21Z","timestamp":1790898261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426001739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2452109426001739"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102166","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Outcomes of Single- and Split-Fraction Low-Dose Radiation in Mycosis Fungoides","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102166"}}